ABINGTON BANCORP, INC./PA·4

Oct 4, 5:54 PM ET

Czerwonka Michael F III 4

4 · ABINGTON BANCORP, INC./PA · Filed Oct 4, 2011

Insider Transaction Report

Form 4
Period: 2011-10-01
Transactions
  • Disposition to Issuer

    Common Stock

    2011-10-016,1200 total(indirect: By IRA)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-10-0160,0000 total
    Exercise: $9.11Exp: 2018-01-30Common Stock (60,000 underlying)
  • Disposition to Issuer

    Common Stock

    2011-10-0138,4000 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-10-0148,0000 total
    Exercise: $7.51From: 2010-07-05Exp: 2015-07-05Common Stock (48,000 underlying)
  • Disposition to Issuer

    Common Stock

    2011-10-0125,6000 total(indirect: By Spouse)
Footnotes (6)
  • [F1]Includes 14,000 shares held jointly with the reporting person's spouse.
  • [F2]Disposed of pursuant to merger agreement between issuer and Susquehanna Bancshares, Inc. ("SUSQ") in exchange for 50,688 shares of SUSQ common stock having a market value of $5.46 per share on the effective date of the merger.
  • [F3]Disposed of pursuant to merger agreement between issuer and SUSQ in exchange for 8,078 shares of SUSQ common stock having a market value of $5.46 per share on the effective date of the merger.
  • [F4]Disposed of pursuant to merger agreement between issuer and SUSQ in exchange for 33,792 shares of SUSQ common stock having a market value of $5.46 per share on the effective date of the merger.
  • [F5]This option, which provided for vesting in five equal annual installments beginning January 30, 2009, was assumed by SUSQ in the merger and replaced with an option to purchase 79,200 shares of SUSQ common stock for $6.91 per share.
  • [F6]This option, which provided for vesting in five equal annual installments beginning July 5, 2006, was assumed by SUSQ in the merger and replaced with an option to purchase 63,360 shares of SUSQ common stock for $5.69 per share.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT